Amount Raised
$145 Million
Round Type
Post-IPO Equity
San FranciscoBiotechnologyHealth CareScience And EngineeringInvestors
Description
On April 21, 2026, Maze Therapeutics, Inc. entered into an underwriting agreement with Leerink Partners LLC, agreeing to issue and sell an aggregate of common stock and pre-funded warrants. The offering includes 5,540,000 shares of its common stock and pre-funded warrants for an additional 850,000 shares. The estimated net proceeds from this offering are approximately $144.7 million, after deducting underwriting discounts
Quick answer
Maze Therapeutics raised $145 Million in a Post-IPO Equity round, dated April 22, 2026. Investors: Leerink Partners LLC. Maze Therapeutics is based in San Francisco, California, United States.
- How much did Maze Therapeutics raise?
- Maze Therapeutics raised $145 Million in a Post-IPO Equity round on April 22, 2026.
- Who invested in Maze Therapeutics?
- Leerink Partners LLC is named as investors in this round.
- What does Maze Therapeutics do?
- Maze Therapeutics is translating novel genetic insights into lifesaving medicines, through an approach that integrates human genetics and functional genomics.
- Where is Maze Therapeutics based and how big is it?
- Maze Therapeutics is based in San Francisco, California, United States. Fundz records about 144 employees.
- Who are the decision-makers at Maze Therapeutics?
- Fundz holds 2 contacts at Maze Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Science And Engineering and Biotechnology around the same time
Companies in the same sectors as Maze Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- OliX Pharmaceuticals raised $89M (Post-IPO Equity) on June 4, 2026.
- Advanced NanoTherapies raised $31M (Series B) on June 2, 2026.
- Psilera raised $8.8M (Seed) on May 28, 2026.
- Degron Therapeutics raised $40M (Series A) on May 14, 2026.
- Ray Therapeutics raised $125M (Series B) on April 21, 2026.
- Orthogon Therapeutics raised $11M (Funding Round) on April 17, 2026.
Who to call at Maze Therapeutics, and when
A new round usually means Maze Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Maze Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Maze Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Maze Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Maze Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Maze Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.